A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2011
12/01/2011	WO2011079213A9 Treating critically ill patients with intravenous ibuprofen
12/01/2011	US20110294902 Pharmaceutical compositions providing enhanced drug concentrations
12/01/2011	US20110294900 Self emulsifying drug delivery system for a curcuminoid based composition
12/01/2011	US20110294898 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride
12/01/2011	US20110294886 Controlled-release tablet formulations of pregabalin
12/01/2011	US20110294883 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
12/01/2011	US20110294878 Inhibitors of Dimethylarginine Dimethylaminohydrolase
12/01/2011	US20110294870 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
12/01/2011	US20110294864 Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents
12/01/2011	US20110294856 Novel oxadiazole derivatives and their medical use
12/01/2011	US20110294854 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS
12/01/2011	US20110294853 Bis Aromatic Compounds for Use in the Treatment of Inflammation
12/01/2011	US20110294849 Aminopyrazole triazolothiadiazole inhibitor of c-met protein kinase
12/01/2011	US20110294843 Administration scheme of polar opioid metabolites for post-operative pain management
12/01/2011	US20110294826 Pyrrolo[2,3-d]pyrimidine compounds
12/01/2011	US20110294825 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294824 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294812 P38 map kinase inhibitors
12/01/2011	US20110294808 Indazole Compounds As CCR1 Receptor Antagonists
12/01/2011	US20110294805 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators and methods of use thereof
12/01/2011	US20110294802 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2011	US20110294801 Macrocyclics pyrimidines as aurora kinase inhibitors
12/01/2011	US20110294796 Benzotriazine inhibitors of kinases
12/01/2011	US20110294794 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/01/2011	US20110294781 Pyrazolo-pyrimidine compounds
12/01/2011	US20110294780 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
12/01/2011	US20110294775 Novel compounds
12/01/2011	US20110294769 Nitrooxy derivatives of glucocorticoids
12/01/2011	US20110294768 Ophthalmic Suspension for Ocular Use
12/01/2011	US20110294765 Procedure for obtaining an aqueous dispersion of alcohols and acids from jojoba oil, processes for obtaining self-emulsified jojoba oil, aqueous dispersions and emulsions of jojoba oil in the same and pharmaceutical or cosmetic compositions comprising the same
12/01/2011	US20110294764 2-METHYLENE-19,26-NOR-(20S)-1alpha-HYDROXYVITAMIN D3
12/01/2011	US20110294763 Transdermal delivery of dicolfenac, carbamazepine and benzydamine
12/01/2011	US20110294759 Once daily formulations of tetracyclines
12/01/2011	US20110294755 Binding of galectin-3 by low molecular weight pectin
12/01/2011	US20110294753 Means and methods for counteracting muscle disorders
12/01/2011	US20110294752 Triterpene compositions and methods for use thereof
12/01/2011	US20110294742 Degradable clostridial toxins
12/01/2011	US20110294736 Compounds and methods for the treatment of autoimmune and inflammatory disease
12/01/2011	US20110294734 Pharmaceutical compositions comprising tgf-beta 1 inhibitor peptides
12/01/2011	US20110294720 Apratoxin therapeutic agents: mechanism and methods of treatment
12/01/2011	US20110294665 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110293753 Tocotrienol Compositions
12/01/2011	US20110293748 Combined preparation for treating sepsis
12/01/2011	US20110293734 New plant derived seed extract rich in essentially fatty acids derived from salvia hispanica l. seed: composition of matter, manufacturing process and use
12/01/2011	US20110293733 Self-assembling nanoparticle drug delivery system
12/01/2011	US20110293730 Polylactide nanoparticles
12/01/2011	US20110293727 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293721 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
12/01/2011	US20110293716 Pharmaceutical formulation containing ibuprofen and codeine
12/01/2011	US20110293715 Pharmaceutical Formulation and Process for Its Preparation
12/01/2011	US20110293713 Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs
12/01/2011	US20110293710 Immunomodulatory properties of lactobacillus strains
12/01/2011	US20110293700 Nanocarrier compositions with uncoupled adjuvant
12/01/2011	US20110293699 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293679 Method for coating microspheres onto a flexible material
12/01/2011	US20110293676 Oral Cephalotaxine Dosage Forms
12/01/2011	US20110293642 Modulation of Splenocytes in Cell Therapy
12/01/2011	US20110293641 A vaccinia virus protein a46 peptide and use thereof
12/01/2011	US20110293635 Composition and methods for modulating toll-like receptor activity
12/01/2011	US20110293628 Pain treatment using erk2 inhibitors
12/01/2011	US20110293607 Antibody Variants Having Modifications In The Constant Region
12/01/2011	US20110293605 Antibody formulation
12/01/2011	US20110293595 Prophylactic and therapeutic treatment of Alzheimer's Disease, neuro-degenerative diseases, protein aggregation diseases, Parkinson's Disease and amyloid diseases, using phytic acid and phytate
12/01/2011	US20110293593 Siva 2 stabilization
12/01/2011	US20110293587 Glucagon analogues
12/01/2011	US20110293586 Glucagon analogues
12/01/2011	US20110293577 Therapeutic Methods Using Adipose Tissue-Derived Cell Suspensions Comprising Adipocytes
12/01/2011	US20110293576 Mesenchymal stromal cell populations and methods of isolating and using same
12/01/2011	US20110293575 Photochemical internalisation of kinase inhibitors
12/01/2011	US20110293565 Novel synthetic agonists of tlr9
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
12/01/2011	US20110293513 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/01/2011	DE102010022602A1 Natural antibiotic and food supplements from plant active ingredients, to treat e.g. cancer, comprises pulverized dried extract comprising e.g. fresh harvested rosemary leaves and peeled garlic toes, where extract is crushed and evaporated
12/01/2011	CA2800958A1 Macrocyclic compounds useful as inhibitors of histone deacetylases
12/01/2011	CA2800693A1 Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
12/01/2011	CA2800383A1 Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
12/01/2011	CA2800382A1 Tamarind seed polysaccharide for use in the treatment of microbial infections
11/2011
11/30/2011	EP2390267A1 Stable and soluble antibodies inhibiting TNF(alpha)
11/30/2011	EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases
11/30/2011	EP2389379A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
11/30/2011	EP2389378A1 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
11/30/2011	EP2389377A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
11/30/2011	EP2389355A1 New crystals of a benzoylbenzeneacetamide derivative
11/30/2011	EP2389197A1 Combinations comprising methotrexate and dhodh inhibitors
11/30/2011	EP2310383B1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/30/2011	EP1938824B1 Medicine, food and drink or feed containing sphingomyelin
11/30/2011	EP1888578B1 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo [4,5-c] quinolinyl)-phenyl]propionitrile as lipid kinase inhibitor
11/30/2011	EP1392823B1 Desaturase genes and uses thereof
11/30/2011	CN202052060U 缓痛贴 Relieve pain stickers
11/30/2011	CN102264736A 作为TRK激酶抑制剂的取代的吡唑并[1，5-a]嘧啶化合物 As the substituted pyrazole TRK kinase inhibitors and [1,5-a] pyrimidine compounds
11/30/2011	CN102264731A 1,2,4-二唑衍生物及其治疗用途 1,2,4-oxadiazole derivatives and their therapeutic use
11/30/2011	CN102264377A 含具有黄嘌呤氧化酶抑制效果以及炎症诱发酶抑制效果的朝鲜当归提取物的治疗痛风用组合物 Gout Korean angelica extract containing having a xanthine oxidase inhibitory effect and the effect of suppressing the inflammation-induced enzyme composition
11/30/2011	CN102260648A 重组鼠骨髓瘤细胞ns0-f10及其应用 Recombinant murine myeloma cells and its application ns0-f10
11/30/2011	CN102260623A 解酒祛湿护肝保健酒及其制备方法 Liver health wine hangover dampness and its preparation method
11/30/2011	CN102260324A 一种炎症前期趋化因子拮抗肽及其制备方法和应用 An inflammatory chemokine antagonistic pre-peptide and its preparation method and application
11/30/2011	CN102260270A N-(2-甲基呋喃[2，3-d]嘧啶-4-基)丙烯酰胺、其制备方法及其用途 N- (2- methyl-furo [2,3-d] pyrimidin-4-yl) acrylamide, their preparation and their use
11/30/2011	CN102260253A 苯并[5,6]环庚基[1,2-b]吡啶衍生物、制备方法、药物组合物及其抗过敏性疾病的用途 Benzo [5,6] use Cycloheptyl [1,2-b] pyridine derivatives, preparation methods, pharmaceutical compositions and anti-allergic diseases
11/30/2011	CN102260242A 甲磺酸伊马替尼多晶型物及其药用组合物 Imatinib mesylate polymorphs and pharmaceutical compositions
11/30/2011	CN102260212A 青藤碱衍生物及其制备方法和应用 Sinomenine derivative and its preparation method and application

1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 1272